<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(7)</volume><submitter>Kaneko A</submitter><journal>Translational Lung Cancer Research</journal><pagination>2522-2536</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12337029</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer</pubmed_title><pmcid>PMC12337029</pmcid><pubmed_authors>Teranishi S</pubmed_authors><pubmed_authors>Fukuda N</pubmed_authors><pubmed_authors>Hara Y</pubmed_authors><pubmed_authors>Nagaoka S</pubmed_authors><pubmed_authors>Somekawa K</pubmed_authors><pubmed_authors>Kobayashi N</pubmed_authors><pubmed_authors>Kaneko T</pubmed_authors><pubmed_authors>Kubo S</pubmed_authors><pubmed_authors>Matsumoto H</pubmed_authors><pubmed_authors>Horita N</pubmed_authors><pubmed_authors>Muraoka S</pubmed_authors><pubmed_authors>Kaneko A</pubmed_authors><pubmed_authors>Kudo M</pubmed_authors><pubmed_authors>Watanabe K</pubmed_authors><pubmed_authors>Katakura S</pubmed_authors></additional><is_claimable>false</is_claimable><name>MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-05-02T02:47:35.561Z</modification><creation>2026-04-07T17:34:43.517Z</creation></dates><accession>S-EPMC12337029</accession><cross_references/></HashMap>